Merck
MRK
#42
Rank
HK$2.705 T
Marketcap
HK$1,097
Share price
-1.43%
Change (1 day)
60.44%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): HK$9.72

According to Merck's latest financial reports the company's current EPS (TTM) is HK$9.93. In 2025 the company made an earnings per share (EPS) of HK$57.35 an increase over its 2024 EPS that were of HK$53.02.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$9.72-83.06%
2025HK$57.358.15%
2024HK$53.024308.46%
2023HK$1.20-97.32%
2022HK$44.9510.92%
2021HK$40.5284.68%
2020HK$21.94-27.2%
2019HK$30.1463.44%
2018HK$18.44151.11%
2017HK$7.34-54.58%
2016HK$16.1730.21%
2015HK$12.42-61.99%
2014HK$32.66180.51%
2013HK$11.64-31.82%
2012HK$17.086.62%
2011HK$16.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51 590.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$52.25 426.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-39.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$24.46 146.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$234.43 2,261.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$127.24 1,181.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.93 50.37%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.62 258.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$25.08 152.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.94-50.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel